What is Flexcerin™?

define

Flexcerin™ is a dietary supplement formulated to promote improved joint function and mobility. Manufactured and distributed in North America and Europe by Vitaloix Laboratories, the beneficial claims of taking Flexcerin™ include the relief of inflammation and pain associated with arthritis. The makers of Flexcerin™ also maintain that the formula can help support bones and joints while stimulating the body to increase production of natural pain killing chemicals, such as endorphins. In addition, Flexcerin™ is formulated with all-natural ingredients and is available without a prescription.

Arthritis is a progressive inflammatory disease that is also classified as an autoimmune disorder. Sometimes arthritis develops as the result of an injury to a joint. However, in most cases, the disease stems from a compromised immune system attacking the synovium, the layer of connective tissue that cushions each joint. In addition, the synovial fluid, which lubricates the joints, is also destroyed. Arthritis is also characterized by faulty collagen synthesis as well as impaired proteoglycans, specialized proteins that form joint cartilage.

Unlike conventional medicine, Flexcerin™ is designed to address these underlying causes of arthritis rather than treat its symptoms. For instance, many standard arthritic medications are disease-modifying antirheumatic drugs (DMARDs), which work by suppressing the immune system. In contrast, Flexcerin™ contains natural compounds that have been studied for their effectiveness in improving symptoms of arthritis, such as glucosamine sulfate, chondroitin sulfate, bromelain, and omega-3 from fish oil.

There is significant clinical evidence that these compounds are effective in reducing physical pain from arthritis. For example, studies have shown that glucosamine sulfate promotes the synthesis of proteoglycans and glycosaminoglycans, protein molecules that are involved in joint repair and connective tissue functioning. Studies have also shown that omega-3 fatty acids inhibit signaling mediators that cause cells to initiate inflammation. Chondroitin sulfate has a similar action as glucosamine sulfate, in addition to increasing joint fluid availability. Both chondroitin sulfate and omega-3 fatty acids block the action of cartilage-eroding enzymes.

Flexcerin™ also contains botanical ingredients, such as boswellia serrata and bromelain. Boswellia serrata is an extract obtained from a tree resin that has anti-inflammatory activity. Bromelain, an enzyme obtained from the pineapple plant, has demonstrated proteinase activity that also exhibits anti-inflammatory and analgesic properties. While Flexcerin™ is considered safe and is generally well tolerated in most people, there are certain precautions to be aware of. This product may not be suitable for those who are allergic to shellfish since glucosamine sulfate is obtained from chitin, the exoskeleton of shellfish. In addition, bromelain may increase the effects of blood-thinning medications, such as warfarin.

Related wiseGEEK articles

Category

wiseGEEK features

Subscribe to wiseGEEK


4
Yes! I am on day 20 and my life has been given back to me by Flexcerin. I am only 40 years old and I was spending 5 out of 7 days in bed in extreme pain. On day two I could barely move when I went to bed. when I woke up the next morning I barely had any pain for the first time in four months. By that afternoon I actually jogged. It just keeps getting better everyday! I will never go without my Flexcerin!

Wendy F

- anon50327
3
I tried flexcerin for my knee pain and it did not seem to work. I took the whole bottle and I still had knee pain sadly.
- DailyBorg39
2
Yes, I tried the product for 6 weeks. I have O.A. in my hips and have not experienced any relief from the product to date.
- anon32936
1
Has anyone tried Flexcerin for joint problems and did it work and how well did it work?
- JamesD

FREE: Subscribe to wiseGEEK

 
    learn more

our strict privacy policy ensures that your email address will be safe



Written by Karyn Maier
Last Modified: 27 October 2009

copyright © 2003 - 2009
conjecture corporation